Pharming Group N.V. (PHAR) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
PHAR currently has 702M outstanding shares. with minimal authorized share overhang for future dilution. The company has minimally diluted shareholders by 3.14% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Apr 02, 2026 |
20-F filing | 701.7M shares outstanding |
700M | 0 |
| Apr 03, 2025 |
20-F filing | 680.3M shares outstanding |
680M | 0 |
| Apr 04, 2024 |
20-F filing | 671.1M shares outstanding |
670M | 0 |
| Apr 05, 2023 |
20-F filing | 656.3M shares outstanding |
660M | 0 |
| Apr 06, 2022 |
20-F filing | 648.7M shares outstanding |
650M | 0 |
| Apr 07, 2021 |
20-F filing | 638.8M shares outstanding |
640M | 0 |
| Nov 25, 2020 |
F-1 filing: This F-1 filing details the estimated expenses associated with the registration of ordinary shares, including SEC registration fees, Nasdaq listing fees, and legal and accounting expenses, totaling $2,380,000. |
N/A | 0 |